Recombinant Human G-CSF/CSF3 Protein

A DNA sequence encoding the Human G-CSF/CSF3 Protein(P09919)(Ala30-Pro204)was expressed with a polyhistidine tag at the N-terminus.

Introducing the Recombinant Human G-CSF/CSF3 Protein, a cutting-edge biotechnological advancement in the field of protein therapeutics. This meticulously engineered protein is derived from human granulocyte colony-stimulating factor (G-CSF/CSF3), offering a highly potent and efficacious solution for various medical applications.

Crafted through state-of-the-art recombinant DNA technology, this protein exhibits exceptional purity, ensuring optimal bioactivity and safety. Its molecular structure mirrors that of the naturally occurring G-CSF/CSF3 protein, enabling seamless integration within the human body.

The Recombinant Human G-CSF/CSF3 Protein boasts an array of therapeutic benefits. Primarily, it stimulates the production and maturation of neutrophils, thereby enhancing the body's innate immune response against infections. Additionally, it accelerates the recovery of neutrophil counts following chemotherapy, minimizing the risk of neutropenia-related complications.

This remarkable protein is meticulously manufactured in compliance with stringent quality control measures, guaranteeing batch-to-batch consistency and reliability. It is available in various formulations, including lyophilized powder and liquid, facilitating convenient administration and storage.

The Recombinant Human G-CSF/CSF3 Protein has garnered widespread recognition within the medical community for its exceptional efficacy and safety profile. Its remarkable therapeutic potential extends to diverse clinical settings, encompassing oncology, hematology, and immunology.

In conclusion, the Recombinant Human G-CSF/CSF3 Protein represents a groundbreaking advancement in protein therapeutics, offering a highly potent and reliable solution for various medical applications. With its unrivaled purity, therapeutic benefits, and meticulous manufacturing process, this protein stands as a testament to the relentless pursuit of scientific excellence and the commitment to improving patient outcomes.